Skip to main content

Precision Medicine in Multiple Sclerosis

Precision medicine is a relatively new concept that has gathered considerable attention over the past 10 years or so. Within the context of multiple sclerosis (MS), precision medicine involves the use of genetics, proteomics, advanced neuroimaging, and biomarkers to accurately define the disease in individuals. In this way, the objective is to improve clinical outcomes by providing patients with specific treatment and care through innovative approaches. This presentation by Prof. Grigoriadis provides the background to precision medicine in MS and presents a roadmap showing how precision medicine can be implemented into the care and treatment of MS patients

Precision medicine represents the most advanced way that individual MS patients can be assessed and treated. 


Nikolaos Grigoriadis
graduated from the Faculty of Medicine of the Aristotle University of Thessaloniki. He did his PhD thesis and residency in Neurology in the same institution. He has been specialized in clinical and experimental Neuroimmunology and CNS immunopathology in a number of research centers and institutions abroad. He is now Professor of Neurology at the Aristotle University of Thessaloniki and Head of the of the B’ Dept of Neurology, AHEPA University Hospital, the MS Centre and the Laboratory of Experimental Neurology and Neuroimmunology ( Professor Grigoriadis is member of various international scientific committees such as the European School of Neuroimmunology, ParadigMS, the subcommittee of ENS for Multiple Sclerosis, the ECTRIMS committee (until 2010), Co-founder and Secretary of the Hellenic Academy of Neuroimmunology ( He is President of the Hellenic Neurological Society. He is Ad Hoc reviewer in more than 40 international scientific journals, co-Ordinator in more than 40 multicenter clinical trials for MS and principal investigator in collaborative research projects for experimental cell therapies in CNS autoimmune demyelination. His field of interests are: Neuroimmunology; Multiple sclerosis; experimental models of autoimmune diseases (EAE etc); neurodegeneration; immunomodulation; cell therapies. He has published more than 180 papers in peer reviewed journals. He has been awarded several times for his scientific work.




  • Directors

  • Author(s)

    Nikolaos Grigoriadis
  • Country

  • Release Date

    April 24, 2021
  • Views


Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.